EMA Clarifies Quality And Equivalence Testing Expectations For Cutaneous Products
New guidance from the European Medicines Agency explains how in vitro and in vivo models may be used instead of clinical data for the purpose of establishing therapeutic equivalence in a stepwise approach.
